Depression
7 videos · last 6 months shuffled daily, then older videos newest first
▶
25:12 How Will FDA Regulate Psychedelics?
The Cancer Letter on the FDA's final guidance for sponsors running trials of psychedelics — psilocybin, LSD and MDMA — and what it means for psycho-oncology.
▶
11:24 Minnesota Clinic Running Psychedelic Drug Trials
Dr. Manoj Doss, founder and CEO of the Institute for Integrative Therapies, tells FOX 9 about the Eden Prairie clinic's role in clinical trials testing psychedelic treatments for PTSD and depression and the race to develop FDA-approved psychedelic drugs.
▶
10:46 The Big Biz Show Interviews Jonathan C. Javitt, NRx Pharmaceuticals
Jonathan C. Javitt, M.D., M.P.H., founder of NRx Pharmaceuticals, on NRX-101 and the Phase 2b/3 trial comparing it with lurasidone in suicidal bipolar depression.
▶
4:09 Lead Researcher on Psilocybin Therapy Trial for Clinicians
Dr. Anthony Back of UW Medicine discusses a clinical trial of psilocybin-assisted psychotherapy for front-line clinicians burned out and depressed during the COVID-19 pandemic, published in JAMA Network Open.
▶
53:57 Early Clinical Trials with Psychedelics and PTSD From PBS
PBS looks at use of Psychedelics including Psilocybin and MDMA with a look at use of the drugs in treating depression in cancer patients and a clinical trial from MAPS using MDMA to to treat PTSD in a former US Soldier.
▶
21:56 Ketamine for Suicidal Depression: Benefits and Risks
Jonathan Javitt, founder and chief scientist of NRx Pharmaceuticals, gives a keynote on the benefits and risks of ketamine for suicidal depression at the Sachs Neuroscience Innovation Forum.
▶
13:34 LSD for Anxiety? Study Finds One Dose Helps for Months
Dr. Josh Eloge, Associate Director at Rush’s Depression Treatment Research Center, joined "ChicagoNOW" to explain LSD research and where psychedelic therapy is headed.